The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Proposed subtypes of post‐COVID‐19 syndrome (or long‐COVID) and their respective potential therapies
Open accessAbstract
Summary: The effects of coronavirus disease 2019 (COVID‐19), a highly transmissible infectious respiratory disease that has initiated an ongoing pandemic since early 2020, do not always end in the acute phase. Depending on the study referred, about 10%–30% (or more) of COVID‐19 survivors may develop long‐COVID or post‐COVID‐19 syndrome (PCS), characterised by persistent symptoms (most commonly fatigue, dyspnoea, and cognitive impairments) lasting for 3 months or more after acute COVID‐19. While the pathophysiological mechanisms of PCS have been extensively described elsewhere, the subtypes of PCS have not. Owing to its highly multifaceted nature, this review proposes and characterises six subtypes of PCS based on the existing literature. The subtypes are non‐severe COVID‐19 multi‐organ sequelae (NSC‐MOS), pulmonary fibrosis sequelae (PFS), myalgic encephalomyelitis or chronic fatigue syndrome (ME/CFS), postural orthostatic tachycardia syndrome (POTS), post‐intensive care syndrome (PICS) and medical or clinical sequelae (MCS). Original studies supporting each of these subtypes are documented in this review, as well as their respective symptoms and potential interventions. Ultimately, the subtyping proposed herein aims to provide better clarity on the current understanding of PCS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED: 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study
Huang, C., Huang, L., Wang, Y., Li, X., Ren, L., Gu, X., Kang, L., Guo, L., Liu, M., Zhou, X., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(20)32656-8 · Cited by 4,084
RetractedThe PRISMA 2020 statement: An updated guideline for reporting systematic reviews
Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., et al. (2021) · BMJ · doi:10.1136/bmj.n71 · Cited by 108,283
Wu, Z., & McGoogan, J. M. (2020) · JAMA · doi:10.1001/jama.2020.2648 · Cited by 17,016
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
Page, M. J., McKenzie, J., Bossuyt, P., Boutron, I., Hoffmann, T., mulrow, C., Shamseer, L., Tetzlaff, J., Akl, E., Brennan, S. E., et al. (2020) · doi:10.31222/osf.io/v7gm2 · Cited by 5,177
The Chronic Fatigue Syndrome: A Comprehensive Approach to Its Definition and Study
Fukuda, K., Straus, S. E., Hickie, I., Sharpe, M. C., Dobbins, J. G., Komaroff, A., & and International Chronic Fatigue Syndrome Study Group. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-121-12-199412150-00009 · Cited by 4,969 · cited 1×
“The 1994 Centres for Disease Control and Prevention's (CDC) one entails severe fatigue lasting for at least 6 months with at least four of the following symptoms: cognitive impairments, tender cervical or axillary lymph nodes, headache, muscle and multi‐joint pain, sore throat, post‐ exertional malaise (PEM) and unref…”
Nalbandian, A., Sehgal, K., Gupta, A., Madhavan, M. V., McGroder, C., Stevens, J. S., Cook, J. R., Nordvig, A. S., Shalev, D., Sehrawat, T. S., et al. (2021) · Nature Medicine · doi:10.1038/s41591-021-01283-z · Cited by 4,862
Extrapulmonary manifestations of COVID-19
Gupta, A., Madhavan, M. V., Sehgal, K., Nair, N., Mahajan, S., Sehrawat, T. S., Bikdeli, B., Ahluwalia, N., Ausiello, J. C., Wan, E. Y., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0968-3 · Cited by 3,185 · cited 1×
“1 | Non‐severe COVID‐19 multi‐organ sequelae (NSC‐MOS) Despite being a respiratory disease, COVID‐19 can affect extrapulmonary organ systems, such as the nervous, gastrointestinal, renal, and cardiovascular systems, through various mechanisms.(64) Considering that tissues or organs may endure sub‐clinical dysfunction…”
BackgroundCharacterizing long COVID in an international cohort: 7 months of symptoms and their impact
Davis, H. E., Assaf, G. S., McCorkell, L., Wei, H., Low, R. J., Re'em, Y., Redfield, S., Austin, J. P., & Akrami, A. (2021) · eClinicalMedicine · doi:10.1016/j.eclinm.2021.101019 · Cited by 2,881
More than 50 long-term effects of COVID-19: a systematic review and meta-analysis
Lopez-Leon, S., Wegman-Ostrosky, T., Perelman, C., Sepulveda, R., Rebolledo, P. A., Cuapio, A., & Villapol, S. (2021) · Scientific Reports · doi:10.1038/s41598-021-95565-8 · Cited by 2,757
Taquet, M., Geddes, J. R., Husain, M., Luciano, S., & Harrison, P. J. (2021) · The Lancet Psychiatry · doi:10.1016/s2215-0366(21)00084-5 · Cited by 2,189 · cited 14×
“Another controlled cohort study involving 236,379 COVID‐19 patients also found that the risks of neurological and psychiatric diseases were higher than matched controls with other respiratory tract infections at 6‐month, especially among those with more severe acute COVID‐19.(58) In another large‐ scaled controlled co…”
BackgroundInfluentialLong covid—mechanisms, risk factors, and management
Crook, H., Raza, S., Nowell, J., Young, M., & Edison, P. (2021) · BMJ · doi:10.1136/bmj.n1648 · Cited by 1,655 · cited 1×
“The specifics of these multi‐organ pathological mechanisms leading to PCS are beyond the scope of this review and have been extensively reviewed elsewhere.(8,65,66) F I GUR E 2 Symptoms of the post‐COVID‐19 syndrome (PCS).”
BackgroundHigh-dimensional characterization of post-acute sequelae of COVID-19
Al-Aly, Z., Xie, Y., & Bowe, B. (2021) · Nature · doi:10.1038/s41586-021-03553-9 · Cited by 1,518 · cited 1×
“), among 73,435 COVID‐19 survivors (non‐hospitalised) compared to matched controls and influenza patients at 4‐month.(57) Another controlled cohort study involving 236,379 COVID‐19 patients also found that the risks of neurological and psychiatric diseases were higher than matched controls with other respiratory tract…”
ResultLong COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments
Yong, S. J. (2021) · Infectious Diseases · doi:10.1080/23744235.2021.1924397 · Cited by 1,339
Self-citationCarruthers, B. M., Jain, A. K., De Meirleir, K. L., Peterson, D. L., Klimas, N. G., Lerner, A. M., Bested, A. C., Flor-Henry, P., Joshi, P., Powles, A. C. P., et al. (2003) · Journal of Chronic Fatigue Syndrome · doi:10.1300/j092v11n01_02 · Cited by 1,180
Sheldon, R. S., Grubb, B. P., Olshansky, B., Shen, W.-K., Calkins, H., Brignole, M., Raj, S. R., Krahn, A. D., Morillo, C. A., Stewart, J. M., et al. (2015) · Heart Rhythm · doi:10.1016/j.hrthm.2015.03.029 · Cited by 1,013 · cited 6×
“This condition may also occur with dizziness, palpitations, blurred vision, headache, generalised weakness, exercise intolerance, and fatigue.(120,121) The prevalence of POTS stands at 0.”
BackgroundInfluentialRespiratory rehabilitation in elderly patients with COVID-19: A randomized controlled study
Liu, K., Zhang, W., Yang, Y., Zhang, J., Li, Y., & Chen, Y. (2020) · Complementary Therapies in Clinical Practice · doi:10.1016/j.ctcp.2020.101166 · Cited by 744
Nasserie, T., Hittle, M., & Goodman, S. N. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.11417 · Cited by 702
Cerebral Micro-Structural Changes in COVID-19 Patients – An MRI-based 3-month Follow-up Study
Lu, Y., Li, X., Geng, D., Mei, N., Wu, P.-Y., Huang, C.-C., Jia, T., Zhao, Y., Wang, D., Xiao, A., et al. (2020) · EClinicalMedicine · doi:10.1016/j.eclinm.2020.100484 · Cited by 614
A systematic review describing the prognosis of chronic fatigue syndrome.
Cairns, R., & Hotopf, M. (2005) · Occupational Medicine · doi:10.1093/occmed/kqi013 · Cited by 395 · cited 1×
“Although symptoms of ME/CFS may improve over the years, full recovery is achieved in about 5% of cases only.(105) The precise biological aetiology of ME/CFS remains undetermined with several proposed theories such as hypometabolism, autoimmunity, chronic inflammation, and dysautonomia.”
BackgroundPostural orthostatic tachycardia syndrome: clinical presentation, aetiology and management
Fedorowski, A. (2019) · Journal of Internal Medicine · doi:10.1111/joim.12852 · Cited by 352 · cited 1×
“Possible aetiologies of POTS include dysautonomia, hypovolaemia, and hyperadrenergic stimulation; possible triggers include surgery, pregnancy, psychological stress, concussion, and, most commonly, infections of the gastrointestinal and respiratory tracts.(121,122) Therefore, COVID‐19, being a respiratory viral diseas…”
BackgroundPostural Orthostatic Tachycardia Syndrome
Bryarly, M., Phillips, L. T., Fu, Q., Vernino, S., & Levine, B. D. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.11.059 · Cited by 245 · cited 1×
“This condition may also occur with dizziness, palpitations, blurred vision, headache, generalised weakness, exercise intolerance, and fatigue.(120,121) The prevalence of POTS stands at 0.”
COVID-19 and pulmonary fibrosis: a potential role for lung epithelial cells and fibroblasts
John, A. E., Joseph, C., Jenkins, G., & Tatler, A. L. (2021) · Immunological Reviews · doi:10.1111/imr.12977 · Cited by 219
Pulmonary rehabilitation for patients with coronavirus disease 2019 (COVID‐19)
Yang, L., & Yang, T. (2020) · Chronic Diseases and Translational Medicine · doi:10.1016/j.cdtm.2020.05.002 · Cited by 153 · cited 2×
“and Yang and Yang.(94) Several uncontrolled, observational studies have also supported the efficacy of pulmonary rehabilitation in improving exercise and lung function capacities, as well as symptoms of fatigue, dyspnoea, and mental health, among COVID‐19 survivors.”
BackgroundSiddiq, M. A. B. (2020) · Turkish Journal of Physical Medicine and Rehabilitation · doi:10.5606/tftrd.2020.6889 · Cited by 117 · cited 2×
“The Swiss Society for Pulmonology and other experts have suggested that pulmonary rehabilitation may help treat COVID‐19 survivors with PFS, post‐ARDS sequelae, or persistent pulmonary symptoms.91–93 In brief, pulmonary rehabilitation entails breathing and aerobic exercises, airway clearance techniques, oxygen and nut…”
Background
Cited by
Pathophysiology and mechanism of long COVID: a comprehensive review
Castanares-Zapatero, D., Chalon, P., Kohn, L., Dauvrin, M., Detollenaere, J., Maertens de Noordhout, C., Primus-de Jong, C., Cleemput, I., & Van den Heede, K. (2022) · Annals of Medicine · doi:10.1080/07853890.2022.2076901 · Cited by 585
Metadata
- Authors
- Yong, S. J., & Liu, S.
- Venue
- Reviews in Medical Virology
- Publisher
- Wiley
- Published
- 2021-12-09
- Volume
- 32
- Issue
- 4
- Pages
- e2315-e2315
- ISSN
- 1052-9276 (ISSN-L)
- 1099-1654
- OpenAlex
- W4200014864
- Cited by
- 165
- References
- 24
- FWCI
- 13.91
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.